Art

J-GLOBAL ID：201802291879469948   Reference number：18A0251397

Factors associated with severe skin disorder after extravasation of intravenously infused antineoplastic agents

抗がん剤の点滴静脈内注射の血管外漏出後の重症皮膚障害の発生要因

Author (13)： MATSUI Yuko (Kanazawa Medical Univ.) ,  MURAYAMA Ryoko (Univ. Tokyo) ,  TANABE Hidenori (Univ. Tokyo) ,  TANABE Hidenori (Terumo Corp.) ,  OE Makoto (Univ. Tokyo) ,  MOTOO Yoshiharu (Kanazawa Medical Univ.) ,  WAGATSUMA Takanori (Kanazawa Medical Univ. Hospital) ,  MICHIBUCHI Michiko (Kanazawa Medical Univ. Hospital) ,  KINOSHITA Sachiko (Kanazawa Medical Univ.) ,  SAKAI Keiko (Kanazawa Medical Univ.) ,  KONYA Chizuko (Kanazawa Medical Univ.) ,  SUGAMA Junko (Kanazawa Univ.) ,  SANADA Hiromi (Univ. Tokyo)
Material： 看護理工学会誌  (Journal of Nursing Science and Engineering)
Volume： 5  Issue： 1  Page： 31-40  Publication year： Jan. 25, 2018 
JST Material Number： F1504A  ISSN： 2188-4323  Document type： Article
Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Reference (19)：

• 1) Infusion Nursing Society. Infusion nursing standards of practice. J Infus Nurs 29 Suppl: S1-S92, 2006.
• 2) Sakaida E, Sekine I, Iwasawa S, et al. Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic. Jpn J Clin Oncol 44: 168-171, 2014.
• 3) Langstein HN, Duman H, Seelig D, et al. Retrospective study of the management of chemotherapeutic extravasation injury. Ann Plast Surg 49: 369-374, 2002.
• 4) Barlock AL, Howser DM, Hubbard SM. Nursing management of adriamycin extravasation. Am J Nurs 79: 94-96, 1979.
• 5) Doellman D, Bowe-Geddes LA, Franklin M, et al. Infiltration and extravasation update on prevention and management. J Infus Nurs 32: 203-211, 2009.

Terms in the title (7)： 抗がん剤 ,  点滴 ,  静脈内注射 ,  血管外漏出 ,  重症 ,  皮膚障害 ,  発生要因